BIO Professional Development
Through a curated network of education alliance partners, BIO offers industry professionals executive training and development resources for accelerating career growth
Clinical Development 201: Phase I
Clinical Development 201: Phase I explores the prerequisites, purpose, design, and conduct of Phase I trials. Topics such as bioequivalence, pharmacokinetics, pharmacodynamics, endpoints, selection of dose, and more are explained in detail.
![bio-course-directory-image-2 (1).png](png/bio-course-directory-image-2%20(1).png)
Clinical Development 201: Phase I Course Trailer
Takeaways
- Requirements for and maintenance of an Investigational New Drug (IND) application and a Clinical Trials Application (CTA).
- Purpose of, and characteristics of Phase 0 and Phase I clinical trials.
- Expectations related to clinical benefit in early clinical trials for a standard development programs, and development of treatments for conditions associated with serious unmet medical need.
- Typical endpoints assessed in Phase I clinical trials.
- Steps to take at the conclusion of the Phase I clinical study.
Download Course Syllabus
Clinical Development 201 Phase I Agenda
Course offered by
![Biotech Primer Logo](png/biotech-primer-500px.png)
![](png/price_big.png)
Course Price:
$150 USD
![](png/bio_price_big.png)
BIO Member Price:
$120 USD
![](png/time_big.png)
Course Length:
55 minutes
![](png/level_big.png)
Course Level:
Intermediate
![](png/completion_period_big.png)
Completion Period:
2 weeks
![](png/format_big.png)
Course Format:
On-Demand
Certificate Requirements
- View the entire course
- Pass course exam with a 70 percent
- Complete the course evaluation